scispace - formally typeset
T

Thomas Vogl

Researcher at Weizmann Institute of Science

Publications -  28
Citations -  1646

Thomas Vogl is an academic researcher from Weizmann Institute of Science. The author has contributed to research in topics: Pichia pastoris & Promoter. The author has an hindex of 18, co-authored 28 publications receiving 1224 citations. Previous affiliations of Thomas Vogl include Institute of Molecular Biotechnology & Queensland University of Technology.

Papers
More filters
Journal ArticleDOI

Regulation of Pichia pastoris promoters and its consequences for protein production

TL;DR: The methylotrophic yeast Pichia pastoris provides a strong, methanol inducible promoter of the alcohol oxidase 1 (AOX1) gene, and the regulation of this promoter has been extensively studied in recent years by characterizing cis-acting sequence elements and trans-acting factors, revealing insights into underlying molecular mechanisms.
Journal ArticleDOI

Combinatorial optimization of CRISPR/Cas9 expression enables precision genome engineering in the methylotrophic yeast Pichia pastoris.

TL;DR: This optimized CRISPR/Cas9 system allows rapid, marker-less genome engineering in P. pastoris enabling unprecedented strain and metabolic engineering applications and demonstrates targeting efficiencies approaching 100%.
Journal ArticleDOI

New opportunities by synthetic biology for biopharmaceutical production in Pichia pastoris

TL;DR: The application of Pichia pastoris for biopharmaceutical production is described and the molecular toolbox available for synthetic biology in P. pastoris is discussed.
Journal ArticleDOI

A Toolbox of Diverse Promoters Related to Methanol Utilization: Functionally Verified Parts for Heterologous Pathway Expression in Pichia pastoris.

TL;DR: With the synthetic biology toolbox presented here, P. pastoris is now equipped with one of the largest sets of strong and co-regulated promoters of any microbe, moving it from a protein production host to a general industrial biotechnology host.
Journal ArticleDOI

Implementing CRISPR-Cas technologies in conventional and non-conventional yeasts: Current state and future prospects.

TL;DR: The comparison of innovative CRISPR-Cas expression strategies in yeasts presented here may also serve as guideline to implement and refine CRISpr-Cas systems for highly efficient genome editing in other eukaryotic organisms.